Department of Pediatric Emergency Center, Hunan Children's Hospital, Changsha, Hunan,China.
Medicine (Baltimore). 2020 Dec 18;99(51):e23500. doi: 10.1097/MD.0000000000023500.
Kikuchi's disease (KD) is a rare form of necrotizing lymphadenitis that rarely occurs in association with hemophagocytic lymphohistiocytosis (HLH) in children.
We report the case of a 4-year-5-month-old boy who suffered from fever, cervical lymphadenopathy, pancytopenia, hypertriglyceridemia, splenomegaly, low NK cell activity.
A diagnosis of KD with HLH was made based on the results of biopsy of cervical lymph node and HLH-2004 trial guidelines.
The patient was treated with corticosteroids, cyclosporine, etoposide, continuous hemodiafiltration (HDF), and plasma exchange (PE).
He showed a complete response to therapy, and his condition gradually improved. He was discharged on day 45 after admission due to his good recovery status.
HLH can be associated with KD, especially in childhood, and may have an aggressive clinical course. Continuous HDF and PE and chemotherapy should be reserved for those patients who fail to respond to IVIG and corticosteroids.
Kikuchi 病(KD)是一种罕见的坏死性淋巴结炎,在儿童中很少与噬血细胞性淋巴组织细胞增生症(HLH)相关。
我们报告了一例 4 岁 5 个月大的男孩,他患有发热、颈淋巴结肿大、全血细胞减少、高甘油三酯血症、脾肿大、NK 细胞活性降低。
根据颈淋巴结活检和 HLH-2004 试验指南的结果,诊断为 KD 合并 HLH。
患者接受了皮质类固醇、环孢素、依托泊苷、连续血液透析滤过(HDF)和血浆置换(PE)治疗。
他对治疗有完全反应,病情逐渐改善。由于恢复良好,他在入院后第 45 天出院。
HLH 可与 KD 相关,特别是在儿童中,且可能具有侵袭性的临床病程。对于那些对 IVIG 和皮质类固醇治疗无反应的患者,应保留连续 HDF 和 PE 及化疗。